Complete Filing Data
Syra Health Corp reported Stockholders Equity of $2.10 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Syra Health Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | -$896.3K | -$3.8M | -$2.9M | -$2.1M |
| Selling General And Administrative Expense | $1.1M | $1.4M | $1.1M | $575.8K |
| Revenue From Contract With Customer Excluding Assessed Tax | $7.2M | $8.0M | $5.5M | $5.6M |
| Operating Income Loss | -$904.3K | -$3.8M | -$2.9M | -$2.1M |
| Operating Expenses | $3.4M | $5.4M | $4.3M | $3.2M |
| Nonoperating Income Expense | $8.0K | $5.6K | -$50.7K | -$28.5K |
| Gross Profit | $2.5M | $1.7M | $1.4M | $1.1M |
| Cost Of Goods And Services Sold | $4.7M | $6.3M | $4.1M | $4.6M |
| Interest Expense Nonoperating | $13.3K | $15.6K | $53.7K | |
| Research And Development Expense | $67.8K | $585.1K | $240.0K | |
| Deferred Revenue Current | $16.6K | $16.6K | ||
| Interest Expense | $53.7K | $28.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$225.9K | -$63.6K | -$472.3K | -$417.5K | -$1.4M | -$1.4M | -$354.4K | -$802.8K | -$785.9K | -$354.5K |
| Selling General And Administrative Expense | $252.4K | $289.1K | $287.3K | $288.3K | $456.6K | $522.8K | $234.1K | $208.4K | $215.5K | $150.5K |
| Revenue From Contract With Customer Excluding Assessed Tax | $1.7M | $1.9M | $1.9M | $2.3M | $2.0M | $1.8M | $1.6M | $979.2K | $1.2M | $1.5M |
| Operating Income Loss | -$232.2K | -$63.2K | -$473.3K | -$428.9K | -$1.4M | -$1.4M | -$343.0K | -$784.0K | -$774.5K | -$346.8K |
| Operating Expenses | $786.7K | $816.1K | $1.1M | $1.1M | $1.7M | $1.7M | $897.6K | $912.1K | $921.6K | $760.6K |
| Nonoperating Income Expense | $6.3K | -$438.00 | $1.1K | $11.4K | $97.00 | -$3.1K | -$11.4K | -$18.8K | -$11.4K | -$7.7K |
| Gross Profit | $554.5K | $752.9K | $589.2K | $668.3K | $350.0K | $299.8K | $554.5K | $128.2K | $147.2K | $413.8K |
| Cost Of Goods And Services Sold | $1.1M | $1.2M | $1.3M | $1.6M | $1.6M | $1.5M | $1.0M | $851.1K | $1.0M | $1.1M |
| Interest Expense Nonoperating | $1.9K | $3.9K | $3.2K | $2.3K | $3.7K | $4.1K | $14.2K | $18.9K | ||
| Research And Development Expense | $816.00 | $29.7K | $37.2K | $34.8K | $277.9K | $277.5K | ||||
| Deferred Revenue Current | $141.6K | $266.6K | $599.2K | $6.1K | $6.1K | $6.1K | $141.6K | |||
| Interest Expense | $4.1K | $14.2K | $11.4K | $7.8K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $2.1M | $2.9M | $4.0M | $710.1K | -$7.1K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.6M | $2.4M | $3.3M | $3.3K | $100.0K |
| Retained Earnings Accumulated Deficit | -$9.7M | -$8.8M | -$5.1M | -$2.1M | |
| Property Plant And Equipment Net | $7.0K | $27.3K | $79.0K | $112.5K | |
| Preferred Stock Shares Designated | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets Current | $205.4K | $276.6K | $389.8K | $222.3K | |
| Operating Lease Right Of Use Asset | $27.4K | $299.2K | $63.2K | $184.3K | |
| Operating Lease Liability Current | $27.4K | $112.0K | $63.2K | $121.1K | |
| Liabilities Current | $674.7K | $613.5K | $910.1K | $1.5M | |
| Liabilities And Stockholders Equity | $2.8M | $3.7M | $4.9M | $2.3M | |
| Liabilities | $674.7K | $800.8K | $910.1K | $1.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$780.7K | -$884.7K | $3.3M | -$96.7K | |
| Assets Current | $2.7M | $3.4M | $4.8M | $1.4M | |
| Assets | $2.8M | $3.7M | $4.9M | $2.3M | |
| Accrued Liabilities Current | $194.8K | $230.4K | $199.0K | $239.1K | |
| Notes Payable Current | $116.4K | $152.9K | $184.9K | ||
| Repayments Of Notes Payable | $347.6K | $410.7K | $185.7K | ||
| Cash And Cash Equivalents At Carrying Value | $1.6M | $2.4M | $3.3M | ||
| Accounts Payable Current | $463.0K | ||||
| Operating Lease Liability Noncurrent | $187.2K | $63.2K | |||
| Initial Recognition Of Rightofuse Asset And Lease Liability | $325.5K | $131.2K | |||
| Cash | $1.6M | $2.4M | $3.3M | ||
| Accounts Receivable Net Current | $918.4K | $680.8K | |||
| Repayments Of Related Party Debt | $1.1M | $288.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.2M | $2.4M | $2.5M | $3.3M | $2.1M | $3.4M | -$1.2M | -$876.0K | -$74.4K | $1.3M | $1.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.0M | $2.3M | $2.5M | $2.7M | $1.6M | $3.2M | $18.0K | $36.4K | $596.4K | $668.5M | |||
| Retained Earnings Accumulated Deficit | -$9.6M | -$9.4M | -$9.3M | -$8.3M | -$7.9M | -$6.5M | -$4.1M | ||||||
| Property Plant And Equipment Net | $9.2K | $14.6K | $20.6K | $34.6K | $60.2K | $72.0K | $91.3K | ||||||
| Preferred Stock Shares Designated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Other Assets Current | $307.8K | $242.4K | $210.8K | $483.0K | $391.0K | $381.9K | $163.3K | ||||||
| Operating Lease Right Of Use Asset | $43.5K | $22.2K | $54.8K | $325.5K | $351.2K | $31.8K | $94.1K | ||||||
| Operating Lease Liability Current | $43.5K | $22.2K | $54.8K | $108.9K | $106.5K | $31.8K | $94.1K | ||||||
| Liabilities Current | $1.1M | $1.1M | $1.3M | $877.8K | $901.2K | $1.1M | $2.4M | ||||||
| Liabilities And Stockholders Equity | $3.3M | $3.5M | $3.7M | $4.4M | $3.2M | $4.6M | $2.6M | ||||||
| Liabilities | $1.1M | $1.1M | $1.3M | $1.1M | $1.1M | $1.1M | $3.8M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $95.2K | -$42.1K | $593.1K | ||||||||||
| Assets Current | $3.2M | $3.4M | $3.6M | $4.1M | $2.8M | $4.4M | $1.2M | ||||||
| Assets | $3.3M | $3.5M | $3.7M | $4.4M | $3.2M | $4.6M | $2.6M | ||||||
| Accrued Liabilities Current | $224.7K | $124.8K | $211.9K | $309.6K | $174.2K | $319.7K | $274.6K | ||||||
| Notes Payable Current | $188.9K | $86.7K | $75.0K | $240.2K | $114.3K | $99.0K | |||||||
| Repayments Of Notes Payable | $77.9K | $85.9K | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $2.0M | $2.3M | $2.5M | $18.0K | $3.3K | ||||||||
| Accounts Payable Current | $557.1K | $325.0K | $101.7K | $212.9K | $500.1K | $645.6K | |||||||
| Operating Lease Liability Noncurrent | $216.6K | $244.7K | |||||||||||
| Initial Recognition Of Rightofuse Asset And Lease Liability | |||||||||||||
| Cash | $2.0M | $2.3M | $2.5M | $18.0K | $3.3K | ||||||||
| Accounts Receivable Net Current | $926.3K | $886.4K | $1.1M | $1.2M | |||||||||
| Repayments Of Related Party Debt |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $60.1K | $59.8K | $2.9K | |
| Share Based Compensation | $98.6K | $59.8K | $32.8K | $2.9K |
| Net Cash Provided By Used In Operating Activities | -$447.7K | -$2.9M | -$2.8M | -$2.2M |
| Net Cash Provided By Used In Financing Activities | -$332.8K | $2.1M | $6.1M | $2.3M |
| Increase Decrease In Other Current Assets | -$382.3K | -$491.9K | -$203.1K | $200.8K |
| Increase Decrease In Operating Lease Liability | -$105.7K | -$89.5K | -$121.1K | -$95.6K |
| Increase Decrease In Accrued Liabilities | -$35.6K | $55.7K | -$22.7K | $163.7K |
| Increase Decrease In Accounts Receivable | $237.5K | -$379.8K | $59.5K | $940.5K |
| Increase Decrease In Accounts Payable Trade | $145.8K | -$361.3K | $30.6K | $392.3K |
| Payments To Acquire Property Plant And Equipment | $107.00 | $11.1K | $15.3K | $121.3K |
| Net Cash Provided By Used In Investing Activities | -$107.00 | -$11.1K | -$15.3K | -$121.3K |
| Increase Decrease In Deferred Revenue | $16.6K | |||
| Proceeds From Convertible Debt | $1.5M | |||
| Proceeds From Issuance Of Common Stock | $14.8K | $2.5M | $5.3M | $2.3M |
| Increase Decrease In Accounts Receivable Related Parties | -$50.6K | $50.6K | ||
| Increase Decrease In Accounts Payable Related Parties | $72.0K | -$3.2K | -$82.4K | |
| Proceeds From Warrant Exercises | ||||
| Proceeds From Long Term Lines Of Credit | $300.0K | $2.8M | ||
| Proceeds From Related Party Debt | $1.3M | $94.0K | ||
| Payments Of Debt Issuance Costs | $596.1K | |||
| Increase Decrease In Other Operating Capital Net | -$105.7K | -$121.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $14.0K | $14.3K | $14.1K | $1.1K | $1.2K | $1.4K | $1.2K | |
| Share Based Compensation | $32.9K | $14.1K | $1.4K | |||||
| Net Cash Provided By Used In Operating Activities | $158.2K | -$800.7K | -$45.1K | |||||
| Net Cash Provided By Used In Financing Activities | -$63.1K | $764.2K | $647.8K | |||||
| Increase Decrease In Other Current Assets | -$65.8K | -$7.9K | $103.0K | |||||
| Increase Decrease In Operating Lease Liability | -$244.4K | -$31.4K | -$29.6K | |||||
| Increase Decrease In Accrued Liabilities | -$18.5K | $120.7K | -$34.9K | |||||
| Increase Decrease In Accounts Receivable | $265.0K | -$315.0K | -$835.5K | |||||
| Increase Decrease In Accounts Payable Trade | $223.3K | $182.6K | $31.8K | |||||
| Payments To Acquire Property Plant And Equipment | $5.6K | $9.7K | ||||||
| Net Cash Provided By Used In Investing Activities | -$5.6K | -$9.7K | ||||||
| Increase Decrease In Deferred Revenue | $582.6K | $6.1K | ||||||
| Proceeds From Convertible Debt | $1.5M | $1.3M | ||||||
| Proceeds From Issuance Of Common Stock | ||||||||
| Increase Decrease In Accounts Receivable Related Parties | $31.5K | |||||||
| Increase Decrease In Accounts Payable Related Parties | -$1.6K | |||||||
| Proceeds From Warrant Exercises | $14.8K | $850.1K | ||||||
| Proceeds From Long Term Lines Of Credit | $300.0K | |||||||
| Proceeds From Related Party Debt | ||||||||
| Payments Of Debt Issuance Costs | $155.3K | |||||||
| Increase Decrease In Other Operating Capital Net | -$244.4K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 11.9M | 7.6M | 4.9M | 3.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 11.9M | 7.6M | 4.9M | 3.0M |
| Earnings Per Share Diluted | $-0.08 | $-0.50 | $-0.60 | $-0.70 |
| Earnings Per Share Basic | $-0.08 | $-0.50 | $-0.60 | $-0.70 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 11.9M | 11.9M | 11.6M | 7.3M | 6.6M | 6.5M | 4.4M | 4.4M | 4.4M | 4.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 11.9M | 11.9M | 11.6M | 7.3M | 6.6M | 6.5M | 4.4M | 4.4M | 4.4M | 4.1M |
| Earnings Per Share Diluted | $-0.02 | $-0.01 | $-0.04 | $-0.06 | $-0.21 | $-0.22 | $-0.08 | $-0.18 | $-0.18 | $-0.09 |
| Earnings Per Share Basic | $-0.02 | $-0.01 | $-0.04 | $-0.06 | $-0.21 | $-0.22 | $-0.08 | $-0.18 | $-0.18 | $-0.09 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Salaries And Wages | $1.5M | $2.7M | $2.3M | $1.5M |
| Professional Fees | $737.7K | $606.1K | $586.5K | $1.0M |
| Investment Income Interest | $21.3K | $21.2K | $2.9K | $63.00 |
| Depreciation | $20.5K | $62.7K | $48.8K | $14.8K |
| Stock Issued During Period Value Issued For Services | $2.6K | $71.4K | $510.0K | |
| Interest Paid Net | $13.3K | $15.6K | $36.2K | $11.7K |
| Additional Paid In Capital | $11.8M | $11.7M | $9.1M | $2.8M |
| Stock Issued During Period Value New Issues | $14.8K | $850.1K | $4.7M | $2.3M |
| Other Noncash Expense | $89.5K | $95.6K | ||
| Issuance Of Stock And Warrants For Services Or Claims | $2.6K | $71.4K | $510.0K | |
| Notes Issued1 | $311.1K | $378.7K | $370.6K | |
| Repayments Of Lines Of Credit | $1.1M | $2.1M | ||
| Adjustments To Additional Paid In Capital Other | $24.3K | |||
| Stock Issued During Period Value Other | $1.6M | $4.7M | ||
| Stock Issued During Period Value Conversion Of Convertible Securities | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Salaries And Wages | $336.4K | $326.4K | $507.2K | $594.7K | $847.1K | $736.3K | $592.2K | $562.6K | $457.7K | $451.8K |
| Professional Fees | $191.7K | $164.9K | $224.0K | $153.8K | $141.5K | $194.6K | $58.9K | $128.8K | $236.7K | $154.5K |
| Investment Income Interest | $8.2K | $3.4K | $4.3K | $13.6K | $3.8K | $981.00 | $2.8K | $4.00 | $2.00 | $35.00 |
| Depreciation | $5.4K | $6.0K | $6.8K | $25.5K | $17.4K | $12.5K | $12.4K | $12.3K | $11.8K | $3.9K |
| Stock Issued During Period Value Issued For Services | $2.6K | $22.9K | $18.9K | $18.9K | ||||||
| Interest Paid Net | $3.2K | $4.1K | $9.9K | |||||||
| Additional Paid In Capital | $11.8M | $11.8M | $11.7M | $11.6M | $10.0M | $10.0M | $2.8M | |||
| Stock Issued During Period Value New Issues | $14.8K | $850.1K | $514.9K | |||||||
| Other Noncash Expense | $31.4K | $29.6K | ||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $2.6K | $18.9K | ||||||||
| Notes Issued1 | ||||||||||
| Repayments Of Lines Of Credit | $752.0K | |||||||||
| Adjustments To Additional Paid In Capital Other | $14.0K | $14.0K | $16.3K | |||||||
| Stock Issued During Period Value Other | $1.6M | |||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.